Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2003
06/05/2003US20030105050 Disorders caused by overproduction of collagen fibres, for example, liver cirrhosis, kidney, liver and heart fibrosis, scleroderma, hypertrophic scars and keloids
06/05/2003US20030105045 Artificial transcriptional factors and methods of use
06/05/2003US20030105024 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
06/05/2003US20030105018 Using vascular endothelial growth factor (VEGF) and homologues for the manufacture of a medicament to treat neuron disorders
06/05/2003US20030104998 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104975 Useful for identification of compounds that induce or inhibit the recruitment of the p160 family cofactors, especially TIF-2 and/ or SRCs cofactors (Translation initiation factor-2 and steroid receptor cofactors)
06/05/2003US20030104626 Packaging systems for human recombinant adenovirus to be used in gene therapy
06/05/2003US20030104620 Expression vector for expression of heterologous polypeptides and amplification of cell viral resistance; viricides
06/05/2003US20030104606 Biosensor for detection of vibrio luminescent protein; biological pest control; bactericides; gene expression inhibition
06/05/2003US20030104603 Citrate lyase polypeptides which are transcriptionally regulated in adipose tissue; fatty acid metabolism; antidiabetic agents; dietetics; drug screening
06/05/2003US20030104600 Hydrolases; cancer diagnosis; antitumor agents; antisense agents
06/05/2003US20030104599 Polypeptide (suv39h2) having histone methyltransferase activity; antitumor agents; meiotic chromatin; contraceptives
06/05/2003US20030104596 human desaturase gene and uses thereof
06/05/2003US20030104595 Oxidoreductase; probes for accurate measurement and detection of glucose concentration in cell
06/05/2003US20030104582 Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
06/05/2003US20030104576 Methylation inhibitors; vaccines; viricides
06/05/2003US20030104569 Proteins suppressing proliferation of lympho-hematopoietic cells
06/05/2003US20030104557 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptides; cancer diagnosis
06/05/2003US20030104556 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104555 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104554 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypetide; cancer diagnosis
06/05/2003US20030104550 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104549 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104545 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104544 For stimulating release of tumor necrosis factor and or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
06/05/2003US20030104531 DNA molecules encoding human nuclear receptor protein nNR7-1
06/05/2003US20030104528 Lymphocytes; transcription factors; interferons
06/05/2003US20030104526 Rational design of polypeptides containing non-modulatory zinc finger, i.e, its sequence specificity depends on its location in multi-finger protein
06/05/2003US20030104523 Process for high throughput screening of CpG-based immuno-agonist/antagonist
06/05/2003US20030104520 Stable ribozyme for modulation of gene expression; in vitro diagnostic agent; regulatory sequences for medical diagnosis
06/05/2003US20030104517 Kinesin light chain homolog
06/05/2003US20030104516 Protein kinase npk-110
06/05/2003US20030104513 Betaines as adjuvants to susceptibility testing and antimicrobial therapy
06/05/2003US20030104512 Biosensors for single cell and multi cell analysis
06/05/2003US20030104511 Kit for use monitoring bacteriicidal of test compounds
06/05/2003US20030104509 Kit for use in digestion and separation of polypeptide segments
06/05/2003US20030104508 Hematological assay and reagent
06/05/2003US20030104507 Kit for use in monitoring adenine triphosphates in sample
06/05/2003US20030104504 Chemical modification
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104499 Kits for use in diagnosis of cell proliferative disorders
06/05/2003US20030104495 Kinase for use as sex preferential contraceptive
06/05/2003US20030104493 Method for predicting an increased likelihood of antiphospholipid syndrome in a patient
06/05/2003US20030104490 High throughput assay for use in treatment and monitoring of diabetes
06/05/2003US20030104489 Functional assay for agonist activation of receptors
06/05/2003US20030104483 Use of spectrum analysis to determine structural chacteristics of digested proteins
06/05/2003US20030104482 Death associated kinase containing ankyrin repeats (DAKAR)
06/05/2003US20030104479 Novel fusion proteins and assays for molecular binding
06/05/2003US20030104478 Screening modulators of g-protein activity: for use in treatment of nervous system disorders
06/05/2003US20030104477 Immunoglobulin library for use in diagnosis, prevention and treatment of autoimmune diseases
06/05/2003US20030104474 Kit for use in the diagnosis and treatment of cancer
06/05/2003US20030104471 Methods for rapidly indentifying small organic molecule ligands for binding to biological target molecules
06/05/2003US20030104469 Nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of gastrointestinal, cancer and kidney disorders
06/05/2003US20030104467 Process for preparation of full-length cDNA and anchor used for the same
06/05/2003US20030104466 Microfluidic sequencing systems
06/05/2003US20030104465 Solid support for use in analysis of nucleotide sequence samples
06/05/2003US20030104464 Method for the high-parallel analysis of polymorphisms
06/05/2003US20030104462 Analyzing length of teleomers to determine age of mammals
06/05/2003US20030104461 Methods for detecting cells with numerical chromosomal abnormalities
06/05/2003US20030104460 Primers for use as amplification and diagnostic tools in genetic engineering
06/05/2003US20030104459 Primers for use in the amplification of preferential nucleotide sequences
06/05/2003US20030104458 Kit for use in monitoring hybridization activity of nucleotide sequences
06/05/2003US20030104457 Apparatus for use in detection of nucleotide sequences associated with drinking disorders
06/05/2003US20030104455 Methods and compositions for treating urological disorders using 313, 333, 5464, 18817 or 33524
06/05/2003US20030104454 Diagnosis, classification and evaluation of tumor disorders in animals and humans
06/05/2003US20030104453 Pharmacological data base for use in screening and predicting effectivness of drug treatment
06/05/2003US20030104452 Selected primers for detection of MAGE or GAGE genes for diagnosis of cancer and methods of use
06/05/2003US20030104450 Novel regulator of g protein signalling
06/05/2003US20030104448 Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
06/05/2003US20030104447 Nucleotide sequences coding polypeptide for use in treatment and detection of respiratory, skin and infectious disorders
06/05/2003US20030104446 Use of olignucleotides to classify and determine activity of nucleotide sequences maintenance enzymes
06/05/2003US20030104444 Plasmids for use as tools in treatment and prevention of nervous system, cancer and viral disorders
06/05/2003US20030104442 Nucleic acid sequence encoding ovarian antigen, CA125, and uses thereof
06/05/2003US20030104441 Method of concentrating and recovering a viral enzyme activity from biological samples
06/05/2003US20030104440 Use of probes in the calibration of nucleotide sequence pools
06/05/2003US20030104439 Methods of identifying cellular target molecules
06/05/2003US20030104438 Use of fluorescent probes to determine concentration of nucleic acids in sample
06/05/2003US20030104437 Probes for use as tools in determination of nucleotide sequence of target nucleic acids
06/05/2003US20030104436 Oligonucleoties for use in the analysis of cellular activity and viral and phenotypes
06/05/2003US20030104434 Monitoring adjustment in transcription products during gene amplification
06/05/2003US20030104433 Oligonucleotides labeled with stable isotopes and a method for detecting the same
06/05/2003US20030104432 Methods of amplifying sense strand RNA
06/05/2003US20030104431 Nucleic acid amplification using nicking agents
06/05/2003US20030104430 Use of chip for the amplification of target nucleotide sequences
06/05/2003US20030104428 Method for characterization of nucleic acid molecules
06/05/2003US20030104426 Signature genes in chronic myelogenous leukemia
06/05/2003US20030104425 Solid support for use in the analysis and detection of preferential genotypes in animal population
06/05/2003US20030104424 Detection of allelic variation in mammals which is associated with amplified immunities against infection
06/05/2003US20030104423 Transcriptional modulator for use as tool in controlling gene expression
06/05/2003US20030104422 Nucleotide sequences coding enztmatic polypeptide for use as diagnostic tool in genetic engineering
06/05/2003US20030104421 Oligonucleotide for use as primer tools in propagation of preferental nucleotide sequences
06/05/2003US20030104419 Method of classifying a thyroid carcinoma using differential gene expression
06/05/2003US20030104418 Diagnostic markers for breast cancer
06/05/2003US20030104412 Kit for use in diagnosis and detection of tumors
06/05/2003US20030104411 Microarray for use in analysis and classification of biological samples
06/05/2003US20030104410 Human microarray
06/05/2003US20030104408 Generation of genetic map utilizing overlaping nucleotide sequences
06/05/2003US20030104405 Method of differentiating beer yeast
06/05/2003US20030104404 Genetic markers for autoimmune disorder
06/05/2003US20030104400 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infammatory, immunol;ogical and nervous system disorders
1 ... 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 ... 3003